NCT06877260

Brief Summary

Neurodevelopmental disorders (NDDs) are early-onset conditions affecting personal, social, and academic functioning, with high comorbidity rates and shared neurobiological traits. Traditional diagnostic categories struggle to explain symptom overlap, supporting a transdiagnostic approach that views NDDs as dimensions rather than distinct entities. This project aims to identify common neuropsychological and neurophysiological profiles in ADHD, autism, intellectual disability, and learning disorders using high-density EEG and cognitive tasks assessing cognitive control. By integrating neuropsychological assessments, EEG responses, and behavioral data, the study seeks to identify shared functional profiles rather than disorder-specific biomarkers. Additionally, it will analyze the relationship between NDDs and epilepsy to validate behavioral and neurophysiological markers. Conducted in collaboration with the University of Padua, the study employs advanced data analysis to enhance personalized interventions.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
19mo left

Started Nov 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress50%
Nov 2024Nov 2027

Study Start

First participant enrolled

November 1, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

February 26, 2025

Completed
16 days until next milestone

First Posted

Study publicly available on registry

March 14, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
2.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2027

Expected
Last Updated

March 14, 2025

Status Verified

March 1, 2025

Enrollment Period

10 months

First QC Date

February 26, 2025

Last Update Submit

March 10, 2025

Conditions

Keywords

transdiagnostic approachneural fingerprintneurodevelopmental disorders

Outcome Measures

Primary Outcomes (1)

  • EEG amplitude variation

    EEG evoked potentials amplitude measured in micronvolt

    Through study completion, an average of 1 year

Study Arms (1)

Neuropsychological EEG testing

Patients will undergo an EEG and neuropsycholgical tasks evaluation, as well as the control group

Diagnostic Test: Computer based task with EEG

Interventions

Participants will undergo EEG recording while performing a computer based neuropsychological task evaluating cognitive control

Neuropsychological EEG testing

Eligibility Criteria

Age6 Years - 17 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Patients with diagnosis of neurodevelopmental disorders

You may qualify if:

  • Age between 6 and 16 years at the time of the study assessment.
  • Participant's ability to collaborate in performing computerized cognitive tasks.
  • Ability to undergo a neuropsychological assessment in the Italian language

You may not qualify if:

  • Presence of organic disorders such as previous ischemic events, cerebral neoplastic elements, or a clinical history including brain surgery.
  • Age outside the 6-16 years range.
  • Inability to perform computerized cognitive tasks.
  • Inability to undergo a neuropsychological assessment in the Italian language.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCC E.Medea

Conegliano, Italy/Treviso, 31015, Italy

Location

Related Publications (4)

  • Duma GM, Di Bono MG, Mento G. Grounding Adaptive Cognitive Control in the Intrinsic, Functional Brain Organization: An HD-EEG Resting State Investigation. Brain Sci. 2021 Nov 15;11(11):1513. doi: 10.3390/brainsci11111513.

    PMID: 34827511BACKGROUND
  • Dalgleish T, Black M, Johnston D, Bevan A. Transdiagnostic approaches to mental health problems: Current status and future directions. J Consult Clin Psychol. 2020 Mar;88(3):179-195. doi: 10.1037/ccp0000482.

    PMID: 32068421BACKGROUND
  • Joshi G, Faraone SV, Wozniak J, Tarko L, Fried R, Galdo M, Furtak SL, Biederman J. Symptom Profile of ADHD in Youth With High-Functioning Autism Spectrum Disorder: A Comparative Study in Psychiatrically Referred Populations. J Atten Disord. 2017 Aug;21(10):846-855. doi: 10.1177/1087054714543368. Epub 2014 Aug 1.

    PMID: 25085653BACKGROUND
  • Astle DE, Holmes J, Kievit R, Gathercole SE. Annual Research Review: The transdiagnostic revolution in neurodevelopmental disorders. J Child Psychol Psychiatry. 2022 Apr;63(4):397-417. doi: 10.1111/jcpp.13481. Epub 2021 Jul 23.

    PMID: 34296774BACKGROUND

MeSH Terms

Conditions

Neurodevelopmental DisordersDiseaseEpilepsy

Interventions

Electroencephalography

Condition Hierarchy (Ancestors)

Mental DisordersPathologic ProcessesPathological Conditions, Signs and SymptomsBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, NeurologicalDiagnostic Techniques and ProceduresDiagnosisElectrodiagnosis

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 26, 2025

First Posted

March 14, 2025

Study Start

November 1, 2024

Primary Completion

September 1, 2025

Study Completion (Estimated)

November 1, 2027

Last Updated

March 14, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations